VEGFA and breast carcinoma: To validate this hypothesis, an enzyme‐linked immunosorbent assay (ELISA) assay was conducted to quantify the VEGFA levels in conditioned medium derived from breast cancer cells with either GLO1 knockdown or overexpression.